PartitionBio™ awarded grant to exploit its novel biologics shuttle platform for therapeutic nucleic acids delivery

PartitionBio™ is a Cambridge (UK) based biotech start-up company offering a revolutionary technology platform for the non-viral delivery of a broad spectrum of macromolecules with therapeutic potential across the cell membrane. Possible payloads for the shuttle condensates include antibodies, proteins, peptides and nucleic acids. PartitionBio ™  is aCambridge(UK) based biotech start-up company offering a revolutionary technology platform for the non-viral delivery of a broad spectrum of...

PartitionBio™ is a Cambridge (UK) based biotech start-up company offering a revolutionary technology platform for the non-viral delivery of a broad spectrum of macromolecules with therapeutic potential across the cell membrane. Possible payloads for the shuttle condensates include antibodies, proteins, peptides and nucleic acids.

Contact:
Helen Kent-Armes
[email protected] 
07747 806 905

 

View original content:https://www.prnewswire.co.uk/news-releases/partitionbio-awarded-grant-to-exploit-its-novel-biologics-shuttle-platform-for-therapeutic-nucleic-acids-delivery-302174204.html